Although only a few biological activities of TNIK are involved in controlling the Wnt and Smad signaling pathways, we believe that it might be valuable in the early stage of drug discovery to show that the pharmacologic inhibition of TNIK has an anti-EMT effect in cancer cells; this effort could improve the druggability of TNIK, particularly regarding target validation. This evidence concerns the gene TNIK and cancer.